Patents Assigned to Merrell Pharmaceuticals Inc.
  • Patent number: 5677293
    Abstract: The present invention relates to .DELTA..sup.16 unsaturated C.sub.17 heterocyclic steroids which are useful as steroid C.sub.17-20 lyase inhibitors.
    Type: Grant
    Filed: July 15, 1996
    Date of Patent: October 14, 1997
    Assignee: Merrell Pharmaceuticals Inc.
    Inventors: Norton P. Peet, Joseph P. Burkhart, Cynthia A. Gates
  • Patent number: 5677315
    Abstract: The present invention is directed to a new class of cyclic nitrones and their use as spin trapping agents.
    Type: Grant
    Filed: June 2, 1995
    Date of Patent: October 14, 1997
    Assignee: Merrell Pharmaceuticals Inc.
    Inventors: Albert A. Carr, Craig E. Thomas, Ronald C. Bernotas
  • Patent number: 5675009
    Abstract: The present invention is related to a novel process for preparing certain piperidine derivatives which are useful as antihistamines, antiallergy agents and bronchodilators.
    Type: Grant
    Filed: May 1, 1995
    Date of Patent: October 7, 1997
    Assignee: Merrell Pharmaceuticals Inc.
    Inventors: Chi-Hsin Richard King, Michele A. Kaminski
  • Patent number: 5675018
    Abstract: The present invention is directed to a new class of 3-amido and 3-sulfamido-indolyl NMDA antagonists and their use in the treatment of a number of disease states.
    Type: Grant
    Filed: November 6, 1995
    Date of Patent: October 7, 1997
    Assignee: Merrell Pharmaceuticals Inc.
    Inventors: Francesco G. Salituro, Bruce M. Baron
  • Patent number: 5672625
    Abstract: Sulfonic acid stilbenes block the infection of cells by HSV and CMV and these compounds can be used to treat viral infection.
    Type: Grant
    Filed: June 5, 1995
    Date of Patent: September 30, 1997
    Assignee: Merrell Pharmaceuticals Inc.
    Inventors: Alan D. Cardin, A. Stanley Tyms
  • Patent number: 5670143
    Abstract: The preferred oligomers of the present invention are polyureas, polycarbonates, polyesters or polyamides having a number average molecular weight of <10,000. These oligomers are water-soluble, have a rigid backbone, have recurring units coupled by carbonyl linking moieties which have anionic groups, display predominantly linear geomentry such that regular spacing between anionic groups exists in an aqueous medium, and are pharmaceutically-acceptable. The oligomers are useful for the treatment and/or diagnosis of AIDS and ARC.
    Type: Grant
    Filed: May 19, 1995
    Date of Patent: September 23, 1997
    Assignees: Merrell Pharmaceuticals Inc., The Dow Chemical Company
    Inventors: Alan D. Cardin, Richard L. Jackson, Michael J. Mullins
  • Patent number: 5670521
    Abstract: Certain triphenylpiperidines reverse drug resistance in multi-drug resistant tumors. These compounds apparently function by inhibiting a p-glycoprotein pump which becomes activated in late stage tumor development and which is inherently present in tumors from certain origins.
    Type: Grant
    Filed: January 4, 1996
    Date of Patent: September 23, 1997
    Assignee: Merrell Pharmaceuticals Inc.
    Inventors: Jules Freedman, Sai P. Sunkara
  • Patent number: 5670144
    Abstract: The oligomers of the present invention are polyesters having a number average molecular weight of <10,000. These oligomers are water-soluble, have a rigid backbone with a predictable anion spacing, and are pharmaceutically-acceptable. The oligomers are useful for the treatment and/or diagnosis of HSV and HCMV.
    Type: Grant
    Filed: June 6, 1995
    Date of Patent: September 23, 1997
    Assignees: Merrell Pharmaceuticals Inc., The Dow Chemical Company
    Inventors: Alan D. Cardin, Richard L. Jackson, Michael J. Mullins
  • Patent number: 5668143
    Abstract: The present invention relates to heterocyclic benzenesulfonylimine derivatives and their use as inhibitors of Interleukin-1 (IL-1) action. Such inhibitors are useful in the treatment of various disease states as disclosed herein including rheumatoid arthritis, multiple sclerosis, diabetes mellitus, atherosclerosis, septic shock and pulmonary fibrosis.
    Type: Grant
    Filed: July 3, 1996
    Date of Patent: September 16, 1997
    Assignee: Merrell Pharmaceuticals Inc.
    Inventors: George Ku, Boyd L. Harrison, David M. Stemerick
  • Patent number: 5665715
    Abstract: The present invention relates to certain inhibitors of farnesyl:protein transferase which are useful as antineoplastic agents.
    Type: Grant
    Filed: July 28, 1995
    Date of Patent: September 9, 1997
    Assignee: Merrell Pharmaceuticals Inc.
    Inventor: David M. Stemerick
  • Patent number: 5665780
    Abstract: Certain tetraarylethylenes reverse drug resistance in multi-drug resistant tumors. These compounds apparently function by inhibiting a p-glycoprotein pump which becomes activated in late stage tumor development and which is inherently present in tumors from certain origins.
    Type: Grant
    Filed: December 6, 1995
    Date of Patent: September 9, 1997
    Assignee: Merrell Pharmaceuticals Inc.
    Inventor: Sai Prasad Sunkara
  • Patent number: 5663353
    Abstract: The present invention is related to a novel process for preparing certain piperidine derivatives which are useful as antihistamines, antiallergy agents and bronchodilators.
    Type: Grant
    Filed: May 2, 1995
    Date of Patent: September 2, 1997
    Assignee: Merrell Pharmaceuticals Inc.
    Inventors: Chi-Hsin Richard King, Michele A. Kaminski
  • Patent number: 5663448
    Abstract: Compounds of general formula (I), stereosiomers and pharmaceutically acceptable salts thereof, wherein each of Z and Z' are independently H or F; Q is (a), CH(OH), (b); X is H, Br, Cl, F or CF.sub.3 ; Y is H, Br, Cl, F, OH, OR.sub.5, OC(O)R.sub.4, N.sub.3, CN, NO.sub.2, SO.sub.3 H, CO.sub.2 R.sub.4, NH.sub.2, NHR.sub.9, NR.sub.9 R'.sub.9, C(R.sub.6)(R.sub.7)(V'R.sub.8) or C(O)R.sub.7, provided that when both Z and Z' are F, then Y is H or F; V and V' are each independently CH.sub.2 or O; R.sub.1 is H or CH.sub.3 ; R.sub.2, R.sub.9 and R'.sub.9 are each independently (C.sub.1-6)alkyl, or R.sub.2 and V--R.sub.3 taken together with the carbon atom to which they are attached form a 3-6 membered ring; R.sub.3, R.sub.6, R.sub.7 and R.sub.8 are each independently H, (C.sub.1-6)alkyl, or (C.sub.3-6)cycloalkyl; R.sub.4 is H, (C.sub.1-10)alkyl, (C.sub.0-4)alkylene aryl or (C.sub.3-8)cycloalkyl; and R.sub.5 is (C.sub.1-10)alkyl, benzyl, phenethyl or (C.sub.
    Type: Grant
    Filed: November 21, 1995
    Date of Patent: September 2, 1997
    Assignee: Merrell Pharmaceuticals Inc.
    Inventors: Jean-Noel Collard, Jean-Marie Hornsperger, Daniel Schirlin
  • Patent number: 5661167
    Abstract: The present invention relates to compounds of formula 1, ##STR1## including all of its stereoisomers, compositions, and processes for preparation of the same. The compounds of the present invention are also useful in their pharmacological activities as they directly act as inhibitors of prolyl endopeptidase and thereby provide a methods for memory enhancement, preventing or slowing the affects of amnesia or memory deficits.
    Type: Grant
    Filed: December 2, 1996
    Date of Patent: August 26, 1997
    Assignee: Merrell Pharmaceuticals Inc.
    Inventors: Norton P. Peet, Shujaath Mehdi, Joseph P. Burkhart
  • Patent number: 5661160
    Abstract: The present invention relates to substituted pyrrolidinyl-3-yl-alkyl-piperidines, their stereoisomers, and pharmaceutically acceptable salts thereof and processes for preparation of the same. The compounds of the present invention are useful in their pharmacological activities such as tachykinin antagonism, especially substance P and neurokinin A antagonism, and the like. Compounds having the property of tachykinin antagonism are indicated for conditions associated with neurogenic inflammation and other diseases described herein.
    Type: Grant
    Filed: June 7, 1995
    Date of Patent: August 26, 1997
    Assignee: Merrell Pharmaceuticals Inc.
    Inventors: Timothy P. Burkholder, Tieu-Binh Le, Elizabeth M. Kudlacz, George D. Maynard
  • Patent number: 5654484
    Abstract: The present invention relates to a method for the treatment of patients suffering from certain neoplastic disease states which comprises administering a therapeutically effective amount of a compound of the formula: ##STR1## wherein m is an integer 6 to 9, Z is a saturated (C.sub.2 -C.sub.6) alkylene moiety, each R group independently is hydrogen, methyl, ethyl, or n-propyl except that both R groups cannot be hydrogen when Z is a straight chain; or a pharmaceutically acceptable acid addition salt thereof. Said treatment can optionally comprise conjunctive therapy with a polyamine oxidase inhibitor. The invention also relates to certain novel polyamine derivatives.
    Type: Grant
    Filed: June 1, 1995
    Date of Patent: August 5, 1997
    Assignee: Merrell Pharmaceuticals Inc.
    Inventors: Nellikunja J. Prakash, David M. Stemerick, Michael L. Edwards
  • Patent number: 5654477
    Abstract: The present invention relates to a novel enantiospecific processes for preparing (S)-4-amino-hepta-5,6-dienoic acid and pharmaceutically acceptable salts thereof, which is useful as an irreversible inhibitor of GABA-T, to novel intermediates thereof, and a process for preparing an intermediate thereof.
    Type: Grant
    Filed: March 6, 1995
    Date of Patent: August 5, 1997
    Assignee: Merrell Pharmaceuticals Inc.
    Inventor: H. Michael Kolb
  • Patent number: 5654433
    Abstract: The present invention is related to a novel process for preparing certain piperidine derivatives which are useful as antihistamines, antiallergy agents and bronchodilators.
    Type: Grant
    Filed: May 3, 1995
    Date of Patent: August 5, 1997
    Assignee: Merrell Pharmaceuticals Inc.
    Inventors: Chi-Hsin Richard King, Michele A. Kaminski
  • Patent number: 5652370
    Abstract: The present invention is related to a novel process for preparing certain piperidine derivatives which are useful as antihistamines, antiallergy agents and bronchodilators.
    Type: Grant
    Filed: May 2, 1995
    Date of Patent: July 29, 1997
    Assignee: Merrell Pharmaceuticals Inc.
    Inventors: Chi-Hsin Richard King, Michele A. Kaminski
  • Patent number: 5650516
    Abstract: The present invention is related to a novel process for preparing certain piperidine derivatives which are useful as antihistamines, antiallergy agents and bronchodilators.
    Type: Grant
    Filed: May 3, 1995
    Date of Patent: July 22, 1997
    Assignee: Merrell Pharmaceuticals Inc.
    Inventors: Chi-Hsin Richard King, Michele A. Kaminski